OpenVSafe by OpenVAERS
Search V-safe

76G-19835-41068

4 vaccinations 12 coded responses 41 check-ins 12 free-text entries 1 call case
Sex
Female
Age at first dose
31-35
ZIP prefix
631 / MO
Registered
2021-04-19
Relationship
Self
Race
Multiracial
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-04-17
    Dose 1 — Pfizer-BioNTech
  2. 2021-04-19
    Registered in v-safe
  3. 2021-04-19
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Headache, Joint pains · Be unable to do your normal daily activities
    Adult check-in
  4. 2021-04-20
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Itching · Headache, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  5. 2021-04-21
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  6. 2021-04-22
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Itching · Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  7. 2021-04-24
    Health check-in — day 7, dose 1
    Feeling: Good · Headache · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  8. 2021-05-03
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  9. 2021-05-08
    Dose 2 — Pfizer-BioNTech
  10. 2021-05-09
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain, Redness, Swelling, Itching · Fever · Chills, Headache, Joint pains, Nausea · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  11. 2021-05-10
    Survey response — days 1–6 daily, dose 2
    MedDRA: Costochondritis, Lymphadenopathy — Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea, Abdominal pain · Be unable to work, Be unable to do your normal daily activities
    Free text: Swollen lymph nodes and costochondritis
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  12. 2021-05-11
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Poor · Site: Redness, Swelling · Chills, Headache, Fatigue or tiredness, Nausea, Vomiting, Abdominal pain · Be unable to work, Be unable to do your normal daily activities
    Free text: Lymph nodes are swollen
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  13. 2021-05-12
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Redness · Fever · Chills, Nausea, Abdominal pain
    Adult check-in
  14. 2021-05-13
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Fair · Fever · Chills, Headache, Nausea, Abdominal pain · Be unable to work
    Free text: Lymph node swelling
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-05-14
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · Chills, Headache
    Adult check-in
  16. 2021-05-15
    Health check-in — day 7, dose 2
    Feeling: Fair · Fatigue or tiredness
    Adult check-in
  17. 2021-05-22
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  18. 2021-05-29
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  19. 2021-06-07
    Survey response — day 28, dose 2
    MedDRA: Osteitis, Pain in jaw, Temporomandibular joint syndrome — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Jaw pain and inflammation like TMJ. I've actually had it since the vaccine and just realized. It's getting better.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  20. 2021-06-12
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-06-19
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-08-07
    Health check-in — 3 months, dose 2
    Feeling: Fair
    Adult check-in
  23. 2021-11-06
    Health check-in — 6 months, dose 2
    Feeling: Fair
    Adult check-in
  24. 2021-12-17
    Dose 3 — Pfizer-BioNTech
  25. 2021-12-18
    Survey response — days 1–6 daily, dose 3
    MedDRA: Hepatic enzyme increased — Feeling: Poor · Site: Pain, Swelling · Chills, Headache, Fatigue or tiredness, Nausea, Vomiting · Be unable to do your normal daily activities
    Free text: High liver enzymes
    MedDRA releases: 2024-11 · check-in free text available
  26. 2021-12-19
    Health check-in — days 1–6 daily, dose 3
    Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting, Abdominal pain · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit
    Adult check-in
  27. 2021-12-19
    Report sent to call center — days 1–6 daily, dose 3
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Emergency room or emergency department visit · 1 call case(s)
  28. 2021-12-20
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Fever · Chills, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activities
    Adult check-in
  29. 2021-12-20
    Call successful
    Does not wish to fill out VAERS report
  30. 2021-12-22
    Health check-in — days 1–6 daily, dose 3
    Feeling: Poor · Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work or attend school
    Adult check-in
  31. 2021-12-23
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to work or attend school
    Adult check-in
  32. 2021-12-24
    Health check-in — day 7, dose 3
    Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activities
    Adult check-in
  33. 2022-01-07
    Survey response — day 21, dose 3
    MedDRA: Dysphagia, Gastrooesophageal reflux disease — Feeling: Fair · Be unable to do your normal daily activities
    Free text: GERD and difficulty swallowing
    MedDRA releases: 2024-11 · check-in free text available
  34. 2022-01-22
    Health check-in — day 35, dose 3
    Feeling: Fair
    Adult check-in
  35. 2022-01-28
    Survey response — day 42, dose 3
    MedDRA: Flatulence, Nasopharyngitis, Pre-existing disease, Rhinorrhoea, Upper-airway cough syndrome — Feeling: Poor · Be unable to work or attend school
    Free text: Cold or allergies, post nasal drip and runny nose.
    MedDRA releases: 2024-11 · check-in free text available
  36. 2022-03-19
    Health check-in — 3 months, dose 3
    Feeling: Fair
    Adult check-in
  37. 2022-06-17
    Health check-in — 6 months, dose 3
    Feeling: Fair
    Adult check-in
  38. 2022-10-27
    Dose 4 — Pfizer-BioNTech
    Co-administered: Flu
  39. 2022-10-28
    Health check-in — days 1–6 daily, dose 4
    Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activities
    Adult check-in
  40. 2022-10-30
    Survey response — days 1–6 daily, dose 4
    MedDRA: Intermenstrual bleeding, Painful respiration — Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Chest pain when breathing, spotting
    MedDRA releases: 2024-11 · check-in free text available
  41. 2022-10-31
    Survey response — days 1–6 daily, dose 4
    MedDRA: Chest pain, Vaginal haemorrhage — Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Spotting and severe chest pain
    MedDRA releases: 2024-11 · check-in free text available
  42. 2022-11-01
    Survey response — days 1–6 daily, dose 4
    MedDRA: Chest pain, Painful respiration, Vaginal haemorrhage — Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Spotting, chest pain when breathing
    MedDRA releases: 2024-11 · check-in free text available
  43. 2022-11-03
    Survey response — day 7, dose 4
    MedDRA: Lymphadenopathy — Feeling: Poor · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Lymph nodes swollen
    MedDRA releases: 2024-11 · check-in free text available
  44. 2022-11-17
    Survey response — day 21, dose 4
    MedDRA: Chills, Fatigue, Pyrexia — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Continued occasional fevers and chills. Fatigue has worsened.
    MedDRA releases: 2024-11 · check-in free text available
  45. 2022-12-01
    Health check-in — day 35, dose 4
    Feeling: Fair
    Adult check-in
  46. 2022-12-08
    Health check-in — day 42, dose 4
    Feeling: Good
    Adult check-in
  47. 2023-01-29
    Health check-in — 3 months, dose 4
    Feeling: Fair
    Adult check-in
  48. 2023-04-29
    Health check-in — 6 months, dose 4
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-04-17Pfizer-BioNTech
22021-05-08Pfizer-BioNTech
32021-12-17Pfizer-BioNTech No
42022-10-27Pfizer-BioNTech Flu

Call center

1 call center case

1 successful

See the call center timeline

Free text

Release 8 — days 1–6 daily, dose 2

2021-05-10

Systemic reaction (other): Swollen lymph nodes and costochondritis

2021-05-11

Systemic reaction (other): Lymph nodes are swollen

2021-05-13

Systemic reaction (other): Lymph node swelling

Release 8 — day 28, dose 2

2021-06-07

Symptoms: Jaw pain and inflammation like TMJ. I've actually had it since the vaccine and just realized. It's getting better.

Release 10 — days 1–6 daily, dose 3

2021-12-18

Systemic reaction (other): High liver enzymes

Release 10 — day 21, dose 3

2022-01-07

Symptoms: GERD and difficulty swallowing

Release 11 — day 42, dose 3

2022-01-28

Symptoms: Cold or allergies, post nasal drip and runny nose.

Release 12 — days 1–6 daily, dose 4

2022-10-30

Systemic reaction (other): Chest pain when breathing, spotting

2022-10-31

Systemic reaction (other): Spotting and severe chest pain

2022-11-01

Systemic reaction (other): Spotting, chest pain when breathing

Release 12 — day 7, dose 4

2022-11-03

Systemic reaction (other): Lymph nodes swollen

Release 12 — day 21, dose 4

2022-11-17

Symptoms: Continued occasional fevers and chills. Fatigue has worsened.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDChills · · ✓
SDDysphagia · · ✓
SDFatigue · · ✓
SDFlatulence · · ✓
SDGastrooesophageal reflux disease · · ✓
SDNasopharyngitis · · ✓
SDOsteitis ✓ ✓ ✓
SDPain in jaw ✓ ✓ ✓
SDPre-existing disease · · ✓
SDPyrexia · · ✓
SDRhinorrhoea · · ✓
SDTemporomandibular joint syndrome ✓ ✓ ✓
SDUpper-airway cough syndrome · · ✓
SROChest pain · · ✓
SROCostochondritis ✓ ✓ ✓
SROHepatic enzyme increased · · ✓
SROIntermenstrual bleeding · · ✓
SROLymphadenopathy ✓ ✓ ✓
SROPainful respiration · · ✓
SROVaginal haemorrhage · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release